2026
05 Jan
CARMIEL, Israel , Jan. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharm
2025
17 Dec
Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator ®
2025
13 Nov
Company to host conference call and webcast today at 8:00 a.m. EST CARMIEL, Israel , Nov. 13, 2025 /PRNewswire